Interestingly, we found that hyperactivation of the IL‐1 pathway might occur only in a subset of SS patients and adaptive immunity could also play a role in the pathogenic scenario of SS, with a potential significant role of IL‐17 axis. This evidence concerns the gene IL1B and synovial sarcoma.